Insider · CIK 0001209725

GREBOW PETER E

Reports to the SEC for 4 companies · FRAZER, PA

sec.gov

Transactions

Companies

Filings

CIK

0001209725

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2017-05-23	Rebus Holdings, Inc.Common Stock Purchase OptionA Award	Director	AAward	+2,335 sh	—	—	2,335
2016-05-23	Rebus Holdings, Inc.Common Stock purchase optionA Award	Director	AAward	+53K sh	—	—	53,000
2015-05-26	Rebus Holdings, Inc.Common Stock purchase optionA Award	Director	AAward	+53K sh	—	—	53,000
2014-12-18	Q Therapeutics, Inc.Option to Purchase Common StockA Award	Director	AAward	+50K sh	$0.70	+$35K	175,000
2014-03-11	Q Therapeutics, Inc.Option to Purchase Common StockA Award	Director	AAward	+50K sh	$0.70	+$35K	125,000
2014-03-11	Q Therapeutics, Inc.Option to Purchase Common StockA Award	Director	AAward	+50K sh	$0.70	+$35K	125,000
2013-10-24	OPTIMER PHARMACEUTICALS INCD Disposition to Issuer	Director	DDisposition to Issuer	−7,500 sh	$10.75	−$80.6K	7,500
2013-10-24	OPTIMER PHARMACEUTICALS INCStock option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	$0.93	−$9,300	0
2013-10-24	OPTIMER PHARMACEUTICALS INCD Disposition to Issuer	Director	DDisposition to Issuer	−7,500 sh	$10.75	−$80.6K	0
2013-10-24	OPTIMER PHARMACEUTICALS INCStock option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	$3.22	−$32.2K	0
2013-10-24	OPTIMER PHARMACEUTICALS INCStock option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	$1.93	−$19.3K	0
2013-10-24	OPTIMER PHARMACEUTICALS INCStock option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	$1.93	−$9,650	0
2013-10-24	OPTIMER PHARMACEUTICALS INCStock option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	$0.93	−$9,300	0
2013-01-01	OPTIMER PHARMACEUTICALS INCA Award	Director	AAward	+7,500 sh	—	—	15,000
2012-05-31	OPTIMER PHARMACEUTICALS INCA Award	Director	AAward	+2,500 sh	—	—	7,500
2012-01-01	OPTIMER PHARMACEUTICALS INCA Award	Director	AAward	+5,000 sh	—	—	5,000
2012-01-01	Q Therapeutics, Inc.Options to Purchase Common StockA Award	Director	AAward	+25K sh	$1.00	+$25K	25,000
2011-12-06	Q Therapeutics, Inc.Options to Purchase Common StockA Award	Director	AAward	+10.4K sh	—	—	10,420
2010-12-20	CEPHALON INCF Tax Payment	Exec. V.P., Cephalon Ventures	FTax Payment	−1,186 sh	$64.67	−$76.7K	68,195
2010-12-16	CEPHALON INCA Award	Exec. V.P., Cephalon Ventures	AAward	+15K sh	—	—	69,381
2010-12-16	CEPHALON INCNon-Qualified Stock OptionA Award	Exec. V.P., Cephalon Ventures	AAward	+48.4K sh	—	—	48,416
2010-12-16	CEPHALON INCIncentive Stock OptionA Award	Exec. V.P., Cephalon Ventures	AAward	+1,584 sh	—	—	1,584
2010-12-13	CEPHALON INCF Tax Payment	Exec. V.P., Cephalon Ventures	FTax Payment	−1,186 sh	$62.95	−$74.7K	55,567
2010-12-13	CEPHALON INCF Tax Payment	Exec. V.P., Cephalon Ventures	FTax Payment	−1,186 sh	$62.95	−$74.7K	54,381
2010-12-02	CEPHALON INCF Tax Payment	Exec. V.P., Cephalon Ventures	FTax Payment	−1,186 sh	$65.51	−$77.7K	56,753
2010-12-01	OPTIMER PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2010-02-25	CEPHALON INCS Sale	Exec. V.P., Cephalon Ventures	SSale	−15K sh	$67.86	−$1.02M	57,939
2010-01-10	OPTIMER PHARMACEUTICALS INCStock option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2010-01-08	OPTIMER PHARMACEUTICALS INCStock option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2009-12-21	CEPHALON INCF Tax Payment	Exec. V.P., Cephalon Ventures	FTax Payment	−1,522 sh	$59.75	−$90.9K	72,939
2009-12-14	CEPHALON INCF Tax Payment	Exec. V.P., Cephalon Ventures	FTax Payment	−1,522 sh	$59.13	−$90K	74,461
2009-12-11	CEPHALON INCF Tax Payment	Exec. V.P., Cephalon Ventures	FTax Payment	−1,522 sh	$58.94	−$89.7K	75,983
2009-12-02	CEPHALON INCIncentive Stock OptionA Award	Exec. V.P., Cephalon Ventures	AAward	+1,784 sh	—	—	1,784
2009-12-02	CEPHALON INCNon-Qualified Stock OptionA Award	Exec. V.P., Cephalon Ventures	AAward	+48.2K sh	—	—	48,216
2009-12-02	CEPHALON INCA Award	Exec. V.P., Cephalon Ventures	AAward	+15K sh	$56.07	+$841K	77,505
2009-12-01	CEPHALON INCF Tax Payment	Exec. V.P., Cephalon Ventures	FTax Payment	−1,147 sh	$55.32	−$63.5K	62,505
2009-02-19	OPTIMER PHARMACEUTICALS INCStock Option (right to buy)A Award	Director	AAward	+5,000 sh	—	—	15,000
2009-02-19	OPTIMER PHARMACEUTICALS INCStock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2009-01-22	CEPHALON INCW Will/Inheritance	Exec. V.P., Cephalon Ventures	WWill/Inheritance	+300 sh	—	—	63,652
2008-08-04	CEPHALON INCNon-Qualified Stock OptionM Exercise/Conversion	Exec. V.P., Cephalon Ventures	MExercise/Conversion	−25K sh	—	—	23,043
2008-08-04	CEPHALON INCNon-Qualified Stock OptionM Exercise/Conversion	Exec. V.P., Cephalon Ventures	MExercise/Conversion	−20.9K sh	—	—	0
2008-08-04	CEPHALON INCIncentive Stock OptionM Exercise/Conversion	Exec. V.P., Cephalon Ventures	MExercise/Conversion	−2,074 sh	—	—	0
2008-08-04	CEPHALON INCS Sale	Exec. V.P., Cephalon Ventures	SSale	−62.9K sh	$73.59	−$4.63M	51,396
2008-08-04	CEPHALON INCM Exercise/Conversion	Exec. V.P., Cephalon Ventures	MExercise/Conversion	+25K sh	$51.08	+$1.28M	114,322
2008-08-04	CEPHALON INCNon-Qualified Stock OptionM Exercise/Conversion	Exec. V.P., Cephalon Ventures	MExercise/Conversion	−15K sh	—	—	2,920
2008-08-04	CEPHALON INCM Exercise/Conversion	Exec. V.P., Cephalon Ventures	MExercise/Conversion	+22.9K sh	$48.20	+$1.11M	74,322
2008-08-04	CEPHALON INCM Exercise/Conversion	Exec. V.P., Cephalon Ventures	MExercise/Conversion	+15K sh	$48.06	+$721K	89,322
2007-12-19	CEPHALON INCF Tax Payment	Exec. V.P., Cephalon Ventures	FTax Payment	−1,523 sh	$73.90	−$113K	51,396
2007-12-17	CEPHALON INCF Tax Payment	Exec. V.P., Cephalon Ventures	FTax Payment	−3,434 sh	$74.59	−$256K	52,919
2007-12-03	CEPHALON INCF Tax Payment	Exec. V.P., Cephalon Ventures	FTax Payment	−1,523 sh	$74.50	−$113K	41,353

Recent filings

Accepted (ET)
Aug 24
GREBOW PETER E0001615774-17-004013
SEC(opens sec.gov)
Jul 144
GENSPERA INC0001144204-16-112977
SEC(opens sec.gov)
Jun 224
GENSPERA INC0001144204-15-038364
SEC(opens sec.gov)
Dec 224
Q Therapeutics, Inc.0001209191-14-077295
SEC(opens sec.gov)
Mar 134
Q Therapeutics, Inc.0001209191-14-020462
SEC(opens sec.gov)
Oct 284
OPTIMER PHARMACEUTICALS INC0001142576-13-000021
SEC(opens sec.gov)
Aug 135
Q Therapeutics, Inc.0001209191-13-040380
SEC(opens sec.gov)
Jan 34
GREBOW PETER E0001209191-13-001127
SEC(opens sec.gov)
Jun 204
GREBOW PETER E0001142576-12-000022
SEC(opens sec.gov)
Apr 35
GREBOW PETER E0001387131-12-001025
SEC(opens sec.gov)
Jan 34
GREBOW PETER E0001142576-12-000007
SEC(opens sec.gov)
Dec 224
GREBOW PETER E0001187154-10-000075
SEC(opens sec.gov)
Dec 204
GREBOW PETER E0001187154-10-000068
SEC(opens sec.gov)

Companies

Address

41 MOORES ROAD

FRAZER, PA, 19355